Skip to main content

Life Science Analytics Market is Increasing at a Healthy CAGR of 11.91% During Forecast to 2025

Market Highlights:
Life science analytics is a tool that helps in clinical trials standardization and optimization of the drug discovery process.
According to MRFR analysis, the global Life Science Analytics Market Overview is expected to register a CAGR of 11.91% during the forecast period of 2019 to 2025 and was valued at USD 19,165.22 million in 2018.
The growth of the global life science analytics market can be contributed to growing pressure to curb the healthcare expenditure, need for improved data standardization, and increasing prevalence of chronic diseases.
Key Players:
  • Allscripts Healthcare
  • Cerner Corporation
  • CitiusTech Inc
  • Health Catalyst
  • Inovalon
  • McKesson Corporation
  • Saama Technologies
  • Optum
  • SCIOInspire
  • SAS Institute Inc
  • IBM
  • Oracle
  • IQVIA
Segmentation:
  • The global life science analytics market has been segmented based on the type of analytics, application, component, deployment model, and end user.
  • Based on the type of analytics, the global life science analytics market has been segmented into predictive analytics, descriptive analytics, and prescriptive analytics.
  • The global life science analytics market, based on application, has been segmented into research & development, pharmacovigilance, regulatory compliance, sales & marketing, and supply chain optimization.
  • The global life science analytics market has been segmented based on component, as software, services, and hardware.
  • The global life science analytics market has been segmented, on the basis of deployment model, into on-premise and cloud-based.
  • The market based on end user has been segmented into hospitals & clinics, pharmaceutical, biotechnology & medical device companies, and others. Hospitals & clinics segment held the largest market share in 2018 as it helps to minimize the clinical errors and increases healthcare productivity.
Regional Analysis:
Americas: The largest regional market.
North America: The North American market for life science analytics is growing due to the rising investments for technological advancements in the region.
US: The increasing R&D expenditure in the life sciences industry and rising adoption of information technology tools in the life sciences industry is expected to drive the market growth in the US. In 2015, the US spent USD 30.5 billion to support research in the life sciences industry. Thus, a similar trend of increasing R&D expenditure in the life sciences industry is expected to boost market growth during the forecast period.
Latin America: Increasing adoption of advanced technologies in the life sciences analytics industry is anticipated to drive the market growth.
Europe: Government initiatives to curb the healthcare costs, presence of a large number of life science companies and greater availability of life sciences software & services in the region are expected to drive the market growth. For instance, Skane, a city in South Sweden, has more than 300+ life science companies such as AstraZeneca, Getinge and Nobel Biocare, among others. Thus, presence of such international players increases the demand for life science analytical tools to streamline their processes and thereby is expected to drive the market growth.
UK: Increasing adoption of big data in the life sciences industry and high R&D expenditure in the life sciences sector in the UK is expected to drive the market growth.
Germany: The rising number of clinical trials in Germany, leading to the high adoption of analytical solutions for efficiently carrying out the clinical trials, is expected to drive the market growth.
NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Labels:

Comments

Post a Comment

Popular posts from this blog

Covid 19 Analysis on Respiratory Therapeutic Devices Market Analysis and Forecast to 2023

Market Overview: The Global Respiratory Therapeutic Devices Market is predicted to scale to new heights and expand at a CAGR of 10.8% over the forecast period of 2017-2023, asserts Market Research Future (MRFR) in an in-depth study.                   The growth of the Global Covid 19 Analysis on Respiratory Therapeutic Devices Market Analysis   is primarily led by the recent surge in the incidence of chronic respiratory diseases such as asthma, COPD, and sleep disorder breathing. As per the estimates of the World Health Organization (WHO), approximately 235 Mn people suffered from asthma in 2017 across the globe. The growing burden of chronic respiratory diseases (CRDs) induces strong demand for respiratory therapeutic devices within the market. Moreover, with the increase in the global aging population, there is a greater need for respiratory therapeutic devices.     ...
Post a Comment
Read more

Antibody Drug Conjugate Market is Presumed to Grow at a Reliable CAGR of 19% During Forecast to 2023

Antibody Drug Conjugate Market Analysis: Various factors are adding to the global antibody drug conjugate market share. These factors, as per the new MRFR report, include advances in medical technology, rising cases of cancer, growing obese population, and increasing aging population. Additional factors adding market growth include increasing collaborations between biotechnology companies, biopharmaceuticals, and research institutes, rising R&D on oncology diseases, increasing research on advanced drug discoveries, rising number of research on antibody therapies, and preclinical research. The global Antibody Drug Conjugate Market Share is likely to grow at a 19% CAGR between 2017- 2023 , reveals the new Market Research Future (MRFR) report. Antibody drug conjugates are new-age therapeutic agents that have three parts- a chemical linker to attach cytotoxic agents to antibodies, cytotoxic agents for killing target cancer cells, and specific antibodies for binding. Lymphoma, mult...
Post a Comment
Read more

Desalting and Buffer Exchange Market is Growing at a Healthy CAGR of 10.5% During Forecast to 2023

Market Highlights: The Global Desalting and Buffer Exchange Market is anticipated to have held a market value of USD 615.20 million in the year 2017 and is expected to grow at a CAGR of 10.5% during the forecast period. Desalting and buffer exchange play a key role in biotechnological companies. Buffer exchange is used to place a protein solution into a more suitable buffer before applications such as electrophoresis, ion exchange, affinity chromatography among others. Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/6633 Buffer exchange is the term used when one set of buffer salts in a sample is exchanged by another more appropriate buffer set. The rising demand for monoclonal antibodies, growing research and development expenditure by the biopharmaceutical companies, and rising focus on proteomic and genomic research is anticipated to boost the growth of the market over the forecast period. However, the dearth of skilled professionals is excepted to ...
Post a Comment
Read more